Istamet 50mg/500mg Tablet

Ritonavir is a highly potent inhibitor of the CYP3A4 enzyme. In the presence of severe renal impairment or end-stage renal disease, your body's ability to clear sitagliptin is already compromised and relies more on this enzyme, meaning ritonavir can further disrupt sitagliptin processing and raise its concentrations.

These steroid medications possess intrinsic blood-sugar-raising activity. Taking them can directly counteract the glucose-lowering effects of Istamet, causing unexpected spikes in your blood sugar levels and disrupting your overall glycemic control.

These pain-relieving medications can adversely affect your kidney function and decrease the rate at which your body filters waste. Because a drop in kidney efficiency stops metformin from being properly eliminated, it can build up to dangerous levels in your system and significantly increase your risk of developing lactic acidosis.

Clarithromycin works as a strong CYP3A4 inhibitor. In patients with severe kidney impairment or end-stage renal disease, metabolism via this enzyme becomes a primary route for clearing sitagliptin, meaning co-administration can alter how sitagliptin is eliminated and potentially increase its systemic levels.

These blood pressure medications can impair your kidney function, which prevents metformin from being cleared normally and increases the risk of lactic acidosis. Additionally, they possess a separate effect where they can naturally lower your blood glucose levels, which might cause your blood sugar to drop lower than intended when combined with Istamet.

Sitagliptin exerts a small effect on how your body retains digoxin, causing an average increase of 11% in its total blood exposure (AUC) and an 18% increase in its peak concentration (Cmax). Because digoxin has a very narrow safety margin, even small increases can sometimes lead to toxicity.

These cardiovascular medications can cause a decline in your kidney performance. When kidney function is compromised, your body cannot efficiently remove metformin, causing the drug to accumulate in your system and raising the probability of a serious lactic acid buildup.

Itraconazole strongly blocks the CYP3A4 enzyme pathways. For patients suffering from severe kidney impairment or end-stage renal disease, the body relies heavily on this pathway to clear sitagliptin, and blocking it can cause the drug to accumulate in your body.

Dolutegravir acts as an inhibitor against the renal transport systems (OCT2/MATE) that eliminate metformin. By reducing your kidneys' ability to clear metformin, this combination can increase your body's overall exposure to metformin and raise the risk of lactic acidosis.

These water pills can negatively impact your kidney function, which slows down metformin clearance and increases the risk of lactic acidosis. Concurrently, they possess an inherent tendency to raise blood sugar levels, which directly opposes the therapeutic effect of Istamet and can destabilize your diabetes control.

These respiratory medications have inherent blood-sugar-raising properties. When taken alongside Istamet, they can cause your blood glucose levels to elevate significantly, making it harder to maintain stable control over your diabetes.